Blue Earth Diagnostics

Empowering the evolution of care for patients with cancer

Blue Earth Diagnostics is focused on delivering innovative, well-differentiated diagnostic solutions that inform patient care. The Company’s expanding oncology portfolio encompasses a variety of disease states, including prostate cancer and neuro-oncology. Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and therapy.

Blue Earth logo

Blue Earth Therapeutics

Advancing next generation targeted radiopharmaceuticals to treat patients who have cancer

Blue Earth Therapeutics has exclusive worldwide rights to therapeutic applications of radiohybrid Prostate-Specific Membrane Antigen (rhPSMA) radiopharmaceutical technology. The company has an emerging pipeline of precision targeted radiopharmaceuticals, initially focused on prostate cancer, with plans to expand into additional disease areas in oncology.

Blue Earth logo
Blue Earth molecule
The image shown is for illustrative purposes only.

Blue Earth Therapeutics is leveraging its radiopharmaceutical development experience, as demonstrated by the rapid success of its sister company Blue Earth Diagnostics to advance its nuclear medicine portfolio and apply its expertise to the world of next-generation therapeutic radiopharmaceuticals.

Speak with a Bracco account representative
The individuals who appear are for illustrative purposes. All persons depicted are models and not real healthcare professionals.
Speak with a
Bracco account


Find your team

Contact us


Please fill out the form below and we will get back to you

Different countries may have specific processes in place to handle reports of adverse reactions. To report an adverse reaction related to Bracco products, you can find specific contacts and information selecting the page "Pharmacovigilance" of your country.

* I have read the BraccoHealthCare Professionals Privacy Notice and I consent to the processing of my personal data allowing Bracco Imaging SpA (Data Controller) to conduct its business or scientific operations and contact me with promotional communication through email, SMS, and other digital and offline channels, such as mobile apps and social media.